Bachem Holding AG
BANB
Κατάταξη σε μετοχές
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Τιμή μετοχής
$100.60
Κεφαλαιοποίηση
$7.54B
Αλλαγή (1 ημέρα)
-1.49%
Αλλαγή (1 έτος)
49.53%
Χώρα
CH
Εμπόριο Bachem Holding AG (BANB)
Κατηγορία
Healthcare
Δείκτης P/B για Bachem Holding AG (BANB)
Δείκτης P/B στις October 2026 TTM: 4.31
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Bachem Holding AG, ο τρέχων δείκτης P/B (TTM) είναι 4.31. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 3.12.
Ιστορικό P/B για την Bachem Holding AG από 2002 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 4.31 | 40.03% |
| 2025 | 3.08 | -1.34% |
| 2024 | 3.12 | -15.11% |
| 2023 | 3.68 | -26.96% |
| 2022 | 5.03 | -44.38% |
| 2021 | 9.05 | -22.23% |
| 2020 | 11.64 | 143.30% |
| 2019 | 4.78 | 18.05% |
| 2018 | 4.05 | -27.47% |
| 2017 | 5.59 | 66.84% |
| 2016 | 3.35 | 68.44% |
| 2015 | 1.99 | 4.79% |
| 2014 | 1.90 | -2.54% |
| 2013 | 1.95 | 29.71% |
| 2012 | 1.50 | 14.42% |
| 2011 | 1.31 | -37.56% |
| 2010 | 2.10 | -11.45% |
| 2009 | 2.37 | -17.55% |
| 2008 | 2.88 | -18.65% |
| 2007 | 3.54 | 13.43% |
| 2006 | 3.12 | -76.81% |
| 2005 | 13.44 | 424.43% |
| 2004 | 2.56 | 2,367.37% |
| 2003 | 0.10 | 11,444.44% |
| 2002 | 0.00 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| 6.251 | 44.93% |
US
|
|
| 13.2547 | 207.32% |
US
|
|
| 4.4521 | 3.23% |
AU
|
|
| 6.3632 | 47.54% |
NL
|
|
| - | - |
CH
|
